Literature DB >> 6496040

Neuroaxonal pathology of central and peripheral nervous systems in cerebrotendinous xanthomatosis (CTX).

P H Pop, E Joosten, A van Spreeken, A Gabreëls-Festen, H Jaspar, H ter Laak, A Vos.   

Abstract

We studied three siblings and one unrelated patient with cerebrotendinous xanthomatosis (CTX). Of two unrelated patients, we examined biopsies of sural nerve, soleus muscle, and achilles tendon. We also performed neurophysiologic investigations. Another patient died, and a postmortem examination of both brain and spinal cord was made. It was concluded that both the central and the peripheral nervous system were involved in CTX, but the peripheral system only to a slight degree, and that the pathology was predominantly neuroaxonal rather than demyelinating in character.

Entities:  

Mesh:

Year:  1984        PMID: 6496040     DOI: 10.1007/bf00688117

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Terminal innervation ratio in neuromuscular disease. II. Disorders of lower motor neuron, peripheral nerve, and muscle.

Authors:  C Coërs; N Telerman-Toppet; J M Gerard
Journal:  Arch Neurol       Date:  1973-10

2.  Renaut bodies. A forgotten endoneurial structure.

Authors:  A K Asbury
Journal:  J Neuropathol Exp Neurol       Date:  1973-04       Impact factor: 3.685

3.  Cerebrotendinous xanthomatosis. Clinical and pathological studies.

Authors:  J R Schimschock; E C Alvord; P D Swanson
Journal:  Arch Neurol       Date:  1968-06

4.  Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system.

Authors:  J H Menkes; J R Schimschock; P D Swanson
Journal:  Arch Neurol       Date:  1968-07

5.  The experimental production of Renaut bodies.

Authors:  J A Ortman; Z Sahenk; J R Mendell
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

6.  Electron-microscopic heterogeneity of onion-bulb neuropathies of the Déjerine-Sottas type. Two patients in one family with the variant described by Lyon (1969).

Authors:  E Joosten; F Gabreëls; A Gabrèèls-Festen; G Vrensen; J Korten; S Notermans
Journal:  Acta Neuropathol       Date:  1974-02-28       Impact factor: 17.088

7.  Peripheral neuropathy in cerebrotendinous xanthomatosis.

Authors:  A Kuritzky; V M Berginer; A D Korczyn
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

8.  De- and remyelination and onion bulb in cerebrotendinous xanthomatosis.

Authors:  A Ohnishi; Y Yamashita; I Goto; Y Kuroiwa; S Murakami; M Ikeda
Journal:  Acta Neuropathol       Date:  1979-01-12       Impact factor: 17.088

9.  Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.

Authors:  B G Wolthers; M Volmer; J van der Molen; B J Koopman; A E de Jager; R J Waterreus
Journal:  Clin Chim Acta       Date:  1983-06-30       Impact factor: 3.786

  9 in total
  9 in total

1.  Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid.

Authors:  F Ginanneschi; A Mignarri; M Mondelli; G N Gallus; M Del Puppo; S Giorgi; A Federico; A Rossi; M T Dotti
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

2.  Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.

Authors:  Y Hokezu; M Kuriyama; R Kubota; M Nakagawa; J Fujiyama; M Osame
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations.

Authors:  Chiung-Chih Chang; Chun-Chung Lui; Jiun-Jie Wang; Shu-Hua Huang; Cheng-Hsien Lu; Ching Chen; Chih-Feng Chen; Min-Chien Tu; Chi-Wei Huang; Wen-Neng Chang
Journal:  BMC Neurol       Date:  2010-07-06       Impact factor: 2.474

4.  Electrophysiological studies in cerebrotendinous xanthomatosis.

Authors:  Y Tokimura; M Kuriyama; K Arimura; J Fujiyama; M Osame
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

5.  Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging.

Authors:  Matilde Inglese; Nicola De Stefano; Elisabetta Pagani; Maria T Dotti; Giancarlo Comi; Antonio Federico; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

6.  Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.

Authors:  B J Koopman; B G Wolthers; J C van der Molen; W van der Slik; R J Waterreus; A van Spreeken
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

7.  The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.

Authors:  D Soffer; D Benharroch; V Berginer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis.

Authors:  Shu-Fang Chen; Nai-Wen Tsai; Chung-Chih Chang; Cheng-Hsien Lu; Chi-Ren Huang; Yao-Chung Chuang; Wen-Neng Chang
Journal:  BMC Neurol       Date:  2011-05-31       Impact factor: 2.474

9.  Cerebrotendinous xanthomatosis with peripheral neuropathy: a clinical and neurophysiological study in Chinese population.

Authors:  Shu Zhang; Wei Li; Rui Zheng; Bing Zhao; Yongqing Zhang; Dandan Zhao; Cuiping Zhao; Chuanzhu Yan; Yuying Zhao
Journal:  Ann Transl Med       Date:  2020-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.